Publications by authors named "C Martinaud"

Introduction: The VCM is a point-of-care analyzer using a new viscoelastometry technique for rapid assessment of hemostasis on fresh whole blood. Its characteristics would make it suitable for use in austere environments. The purpose of this study was to evaluate the VCM in terms of repeatability, reproducibility and interanalyzer correlation, reference values in our population, correlation with standard coagulation assays and platelet count, correlation with the TEG5000 analyzer and resistance to stress conditions mimicking an austere environment.

View Article and Find Full Text PDF

Background: The Golden Hour Box (GHB), an iceless blood container designed for transfusion closest to the point of injury, is used by military medical teams in remote damage control resuscitation. While its performance is well-established in hot environments, it remains underexplored in cold conditions, a significant consideration in emerging global conflict zones.

Study Design And Methods: Four GHBs were preconditioned at +4°C or +18°C for 8 h and subsequently exposed to controlled laboratory simulated temperatures of -5, -15, and -25°C for 100 h.

View Article and Find Full Text PDF

Background And Objectives: Screening for red blood cell alloantibodies (RBC-Ab) is a critical step in ensuring blood transfusion safety performed by blood donation screening laboratories. We aim to evaluate the prevalence of the RBC-Ab among healthy blood donors.

Materials And Methods: Antibody screening of serum of all voluntary blood donors was performed as a routine immune-haematological procedure by a solid-phase method on a fully automated immunohaematology analyser.

View Article and Find Full Text PDF
Article Synopsis
  • Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can cause symptoms from mild to severe, with convalescent COVID plasma (CCP) showing potential therapeutic benefits in some patients by reducing COVID-19 severity.
  • The study tested pooled lyophilized CCP from recovered patients to see if it maintained the ability to neutralize the virus, comparing antibody levels and effectiveness before and after processing.
  • Results showed that the neutralizing antibodies in the lyophilized CCP had minimal loss of efficacy after treatment, indicating it could still be a valuable therapeutic option.
View Article and Find Full Text PDF